Neurocrine Biosciences | 당기 순이익





당기 순이익 변화 날짜
AbbVie USD 1.82B 1.63B 2025-12
Acadia Pharmaceuticals USD 71.78M 45.11M 2025-09
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
ALKERMES USD 82.76M 4.34M 2025-09
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Cytokinetics USD -306.18M 171.81M 2025-09
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Exelixis USD 193.58M 8.73M 2025-09
Gilead Sciences USD 2.18B 869M 2025-12
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Prothena USD -36.54M 89.23M 2025-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Repligen USD 14.91M 44K 2025-09
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
Teva Pharmaceutical Industries USD 480M 47M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Xoma USD -17.24M 33.23M 2024-09


Neurocrine Biosciences 당기 순이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.